human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 12 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 12 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 12 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 16 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 16 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 16 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 20 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 20 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 20 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 24 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 24 h post-transfection
human DR-GFP/U2OS cells that were transfected with pCBASce plasmid and collected at 24 h post-transfection
human DR-GFP/U2OS cells that were transfected with a control plasmid and collected at 20 h post-transfection
human DR-GFP/U2OS cells that were transfected with a control plasmid and collected at 20 h post-transfection
human DR-GFP/U2OS cells that were transfected with a control plasmid and collected at 20 h post-transfection

treatment: transfected with pCBASce plasmid and collected at 12 h post-transfection.
treatment: transfected with pCBASce plasmid and collected at 16 h post-transfection.
treatment: transfected with pCBASce plasmid and collected at 20 h post-transfection.
treatment: transfected with pCBASce plasmid and collected at 24 h post-transfection.
treatment: transfected with a plasmid having the same vector backbone but missing I-SceI and collected at 20 h post-transfection as control.